EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pelargonidin protects retinal ganglion cells in a streptozotocin-induced diabetic rat model by reducing intraocular pressure, suppressing TGF-β and activating JAK2/STAT3 signalling pathway

Haichun Yu, Ashraf Albrakati, Ejaz Akbar Wani, Ying Li iD

Acta Pharmaceutica · 01.06.2026 · 76 (2) · 1-15

DOI: 10.2478/acph-2026-0010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica, online erschienen am 30.06.2026. Verfasst von Haichun Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Anesthesiology, Xindu District, People' Hospital of Chengdu , Chengdu610500, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Retinal Ganglion Cells, Intraocular Pressure, Transforming Growth Factor beta. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR) is one of the primary causes of vision impairment, affecting individuals with diabetes, and is marked by the neurodegeneration of the retina along with increased intraocular pressure (IOP). This study sought to determine the effects of pelargonidin on extracellular matrix (ECM) modulation and the inhibition of transforming growth factor-β (TGF-β) and Janus Kinase 2/Signal Transducer and Activator of Transcription 3 (JAK2/STAT3) pathway in retinal ganglion cells of streptozotocin-induced diabetic rats. Male Sprague-Dawley rats (180–200 g) were rendered diabetic by intraperitoneal administration of streptozotocin (STZ). The rats were divided into 5 groups: control, diabetic model (STZ), STZ + low dose pelargonidin (12.5 mg kg –1 per day), STZ + medium dose pelargonidin (25 mg kg–1 per day) and STZ + high dose pelargonidin (50 mg kg –1 per day). IOP was monitored using a tonometer. Whole-mount retinal immunofluorescence staining using RNA-binding protein with multiple splicing (RBPMS) was performed to assess retinal ganglion cell (RGC) density. Protein expression levels of apoptotic markers, ECM components, and TGF-β and JAK2/STAT3 signalling pathways were evaluated by Western blotting. Pelargonidin treatment dose-dependently reduced the elevated IOP. Importantly, immunofluorescence analysis revealed a marked dose-dependent preservation of retinal ganglion cell (RGC) density: STZ-induced RGC loss was significantly reversed by pelargonidin, with the highest dose restoring RGC density to near-control or higher levels in both the central and peripheral retina. This was achieved via modulation of apoptosis-related proteins through the upregulation of Bcl-xL, Bcl-2, and downregulation of Bad, Bax and cleaved caspase-3. Furthermore, pelargonidin modulated ECM remodelling protein expression in the RGC layer. In particular, TGF-β2/Smad2/3 signalling was downregulated, and the JAK2/STAT3 pathway was upregulated. By reducing IOP, preserving RGC density, modulating ECM deposition, inhibiting TGF-β and upregulating the JAK2/STAT3 pathway, pelargonidin exerts protective effects against diabetic retinal injury. The results of this study further confirm the pharmacological potential of pelargonidin as a therapeutic agent for diabetic retinopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalRetinal Ganglion CellsIntraocular PressureTransforming Growth Factor betaDiabetic RetinopathyAnthocyaninsAnimalsMaleJanus Kinase 2STAT3 Transcription FactorRats, Sprague-DawleySignal TransductionRatsStreptozocinDose-Response Relationship, Drug

Stichwörter der Autor:innen

TGF-βdiabetic retinopathyintraocular pressurepelargonidinretinal ganglion cells

Substanzen

Janus Kinase 2STAT3 Transcription FactorJak2 protein, ratStat3 protein, ratTransforming Growth Factor betaAnthocyaninsStreptozocin

Autor:innen und Institutionen

  • 1Department of Anesthesiology, Xindu District, People' Hospital of Chengdu , Chengdu610500, China.
  • 2Human Anatomy Department, College of Medicine, Taif University, TaifSaudi Arabia.
  • 3Department of Ophthalmology Government Medical College Srinagar, 190010 J&K, India.
  • 4Department of Endocrinology, Xi 'an Trade Union Hospital , Xi 'an 710100, China.

ORCID-Profile: Ying Li

Zitieren

APA

Yu, H., Albrakati, A., Wani, E. A., & Li, Y. (2026). Pelargonidin protects retinal ganglion cells in a streptozotocin-induced diabetic rat model by reducing intraocular pressure, suppressing TGF-β and activating JAK2/STAT3 signalling pathway. Acta Pharmaceutica, 76(2), 1-15. https://doi.org/10.2478/acph-2026-0010

Vancouver

Yu H, Albrakati A, Wani EA, Li Y. Pelargonidin protects retinal ganglion cells in a streptozotocin-induced diabetic rat model by reducing intraocular pressure, suppressing TGF-β and activating JAK2/STAT3 signalling pathway. Acta Pharmaceutica. 2026;76(2):1-15. doi:10.2478/acph-2026-0010

BibTeX
@article{Yu2026,
  author = {Yu, Haichun and Albrakati, Ashraf and Wani, Ejaz Akbar and Li, Ying},
  title = {Pelargonidin protects retinal ganglion cells in a streptozotocin-induced diabetic rat model by reducing intraocular pressure, suppressing TGF-β and activating JAK2/STAT3 signalling pathway},
  journal = {Acta Pharmaceutica},
  year = {2026},
  volume = {76},
  number = {2},
  pages = {1--15},
  doi = {10.2478/acph-2026-0010}
}
Kostenlos starten →